Cybin Corp.

Private Company

Company Logo
upcoming listing

Company Overview

Cybin Corp. is focused on furthering the research and development of psilocybin through its wholly-owned subsidiary, Serenity Life Sciences Inc., and developing proprietary medicinal mushroom products through its wholly-owned subsidiary, Natures Journey Inc. 

The company's IP strategy revolves around psychedelic delivery mechanisms, synthetic compounds, extraction methods, isolation of chemical compounds, new drug formulations, and protocol regiments. Its experienced management team has run multiple clinical trials and successfully brought many new drugs to market in the past.

Management Team


Paul Glavine
CEO

John Kanakis
Co-Founder & SVP Business Development

Eric So
Co-Founder & President

Lori Challenger
Regulatory Compliance

Sign Up for Alerts

Receive an email alert every time a company announces a merger, capital raise or files for an IPO.

Company Profile

Website

Twitter

Presentation